Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• Efficient gene delivery into human B lymphocytes is crucial for understanding cellular functions.
• Previous adenoviral vectors showed limited efficiency in transducing normal B cells.

Purpose of the Study:

• To compare the gene transfer efficiency of the Ad5/F35 adenoviral vector against the parental Ad5 vector in human B lymphocytes.
• To assess the suitability of Ad5/F35 for functional gene characterization in B lymphopoiesis.

Main Methods:

• Human peripheral blood B cells were cultured in vitro.
• Cells were infected with replication-defective Ad5 and Ad5/F35 vectors carrying the GFP reporter gene.
• Transduction efficiency was quantified using flow cytometry, and B cell physiology was monitored.

Main Results:

• Ad5/F35 transduced up to 60% of human B lymphocytes, a significant improvement over Ad5 (approx. 5%).
• GFP expression was detectable for up to 5 days post-infection.
• B lymphocyte proliferation, viability, and antibody secretion remained unaffected by Ad5/F35 transduction.
• Memory B lymphocytes showed higher susceptibility to Ad5/F35 than naïve B lymphocytes.

Conclusions:

• The Ad5/F35 adenoviral vector is a highly efficient tool for gene transfer into human B lymphocytes.
• Ad5/F35 allows for the functional characterization of genes in B lymphopoiesis without compromising B cell physiology.
• This vector holds promise for advancing research in B cell biology and related immune disorders.